Stay updated on JS002 Multiple-dose Safety and Efficacy in Hyperlipidemia Clinical Trial
Sign up to get notified when there's something new on the JS002 Multiple-dose Safety and Efficacy in Hyperlipidemia Clinical Trial page.

Latest updates to the JS002 Multiple-dose Safety and Efficacy in Hyperlipidemia Clinical Trial page
- Check7 days agoChange DetectedA new revision entry 'Revision: v3.6.6' was added to the record history, updating the version history for the study page. The prior revision entry 'Revision: v3.6.5' was removed.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe history now records a new revision entry (v3.6.5) and removes the previous revision (v3.6.4) from the visible history, indicating the latest version of the study record has been posted.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page history now includes a new revision entry labeled v3.6.4, added to replace the previous v3.6.3 entry.SummaryDifference0.1%

- Check64 days agoChange DetectedThe record history now shows a new site release, version 3.6.3, replacing the previous 3.6.2 entry.SummaryDifference0.1%

- Check71 days agoChange DetectedA new revision entry v3.6.2 was added to the study's record history and the previous v3.6.0 entry was removed, updating the revision log for the record. This is an administrative version control change that does not modify study data or public content.SummaryDifference0.1%

- Check85 days agoChange DetectedThe record history now shows that recruitment is closed with a 'No longer looking for participants' entry, indicating the study is not enrolling. This update is paired with a new version note (v3.6.0) and the removal of the older revision label (v3.5.5) to reflect changes in the study’s version history.SummaryDifference0.4%

Stay in the know with updates to JS002 Multiple-dose Safety and Efficacy in Hyperlipidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JS002 Multiple-dose Safety and Efficacy in Hyperlipidemia Clinical Trial page.